Highmark Medicare Services - A CMS Contractor - ISO 9001:2000 Certified
Basic Search >
 
NOTE: This is a PREVIOUS VERSION. A more current version of this document is available.

Contractor Information

Contractor Name:

Highmark Medicare Services

Contractor Number:

12102, 12202, 12302, 12501, 12301, 12201

Contractor Type:

MAC Part A & B

LCD Information

LCD Database ID Number

L27504

LCD Title

Non-Invasive Cerebrovascular Arterial Studies

Contractor’s Determination Number

L27504

AMA CPT/ADA CDT Copyright Statement

CPT codes, descriptions and other data only are copyright 2007 American Medical Association (or such other date of publication of CPT). All Rights Reserved. Applicable FARS/DFARS Clauses Apply. Current Dental Terminology, (CDT) (including procedure codes, nomenclature, descriptors and other data contained therein) is copyright by the American Dental Association. © 2002, 2004 American Dental Association. All rights reserved. Applicable FARS/DFARS apply.

CMS National Coverage Policy

Title XVIII of the Social Security Act, Section 1862(a)(1)(A) states that no Medicare payment shall be made for items or services which are not reasonable and necessary for the diagnosis or treatment of illness or injury.

Title XVIII of the Social Security Act, Section 1862(a)(7).  This section excludes routine physical examinations.

Title XVIII of the Social Security Act, Section 1833(e) states that no payment shall be made to any provider for any claim that lacks the necessary information to process the claim.

Medicare Benefit Policy Manual-Pub. 100-02.

CMS Internet On-Line Manual Pub. 100-3, Chapter 1, Section 20 and 220.

Primary Geographic Jurisdiction

Pennsylvania, Maryland, District of Columbia, Delaware

Oversight Region

Central Office

Original Determination Effective Date

For services performed on or after 07/11/2008

Original Determination Ending Date

N/A

Revision Effective Date

For services performed on or after 08/01/2008

Revision Ending Date

08/31/2008

Indications and Limitations of Coverage and/or Medical Necessity

Compliance with the provisions in this policy may be monitored and addressed through post payment data analysis and subsequent medical review audits.

Non-invasive tests for cerebrovascular arterial function document the nature, location, extent and severity of disease in extracranial and intracranial vessels, including the carotid and vertebral arteries.

There are numerous tests that measure various aspects of vascular anatomy and physiology as follows:

Direct tests:

  • Carotid phonoangiography
  • Direct bruit analysis
  • Spectral bruit analysis
  • Doppler flow velocity
  • Ultrasound imaging, including real time, B-scan and Doppler

Indirect tests:

  • Periorbital directional Doppler ultrasonography
  • Oculoplethysmography and ophthalmodynamometry

Extracranial cerebrovascular testing uses duplex ultrasonography as the primary testing technique. Protocols must encompass both real-time gray scale imaging (B-mode) and analysis of the angle corrected Doppler spectrum.

Duplex Scan

This procedure combines high-resolution B-mode real-time imaging with Doppler ultrasound and spectral analysis. The scan provides anatomic and hemodynamic information regarding the cervical carotid arteries. Data regarding percent stenosis and characterization of atheromatous plaque are provided. Color-flow Doppler is used to enhance conventional data acquisition.

Physiologic Studies

This term implies functional measurement procedures including Doppler ultrasound studies, ocular pneumoplethysmography, blood pressure measurement, transcutaneous oxygen tension measurements and/or plethysmography. A complete study includes pressure measurements and an additional physiologic technique (e.g., Doppler waveforms or plethysmography). Plethysmography implies volume measurement procedures including air, impedance or strain gauge methods.

Transcranial Doppler

Pulsed Doppler ultrasound is used to interrogate the intracranial vasculature of the Circle of Willis. Its value has been established in detecting severe stenoses in the major intracranial arteries, assessing patterns and extent of collateral circulation in patients with known regions of severe stenosis or occlusion, and evaluating and following patients with vasoconstriction particularly after subarachnoid hemorrhage.

Covered Indications

Vascular studies include supervision of the study and interpretation of study results together with hard copy output and analysis of all data (including bidirectional vascular flow or imaging when provided). A hard copy, or a soft copy convertible to a hard copy provides a permanent record of the study performed and must be of a quality that meets accepted radiologic/ultrasonographic standards. These studies also include patient care required to perform the studies.

The following are covered indications for Duplex scans, Doppler Ultrasound with Spectrum Analysis, Ocular Pneumoplethysmography, and Periorbital Doppler (CPT codes 93875, 93880, and 93882):

  • Cervical bruits or pulsatile tinnitus
  • Pulsatile neck masses
  • Amaurosis fugax
  • Focal cerebral or ocular transient ischemic attacks (i.e., localizing symptoms, weakness of one side of the face, slurred speech, weakness of a limb, incoordination or limb dysfunction)
  • Follow-up of patients with proven carotid disease who are receiving medical therapy
  • Follow-up for postoperative patients following carotid endarterectomy
  • Hemispheric neurologic symptoms of stroke
  • Blunt neck trauma
  • Subclavian steal syndrome
  • Retinal arterial emboli
  • Evaluation of suspected dissection
  • Vasculitis of the extracranial carotid arteries
  • Cerebral embolization
  • Evaluation and follow-up of asymptomatic bruits
  • Follow-up of carotid stent placement

The following are covered indications for Transcranial Doppler (TCD) (CPT codes 93886, 93888, 93890, 93892 & 93893):

  • Detection of severe stenosis in the major basal intracranial arteries
  • Assessment of patterns and extent of collateral circulation in patients with known regions of severe stenosis or occlusion
  • Intraoperative and perioperative monitoring of intracranial flow velocity and hemodynamic patterns during carotid endarterectomy
  • Evaluation and follow-up of patients with vasoconstriction or spasm resulting from an illness, disease or injury, especially after subarachnoid hemorrhage
  • Detection of arteriovenous malformations and study of the supply arteries and flow patterns
  • As an adjunct in the assessment of patients with suspected brain death
  • Evaluation of invasive therapeutic interventions for cerebral malformations
  • Evaluation of cerebral embolization

Coverage Limitations

Any vascular studies performed should be as a result of, or to complement, a thorough patient evaluation and neurological examination.

The use of a simple hand-held or other Doppler device that does not produce hard copy output, or that produces a record that does not permit analysis of bidirectional vascular flow, is considered to be part of the physical examination of the vascular system and is not separately reimbursable. Doppler procedures performed with zero-crossers (i.e., analog [strip chart recorder] analysis) are also included in the office visit.

Non-invasive vascular studies done for screening purposes (i.e., without signs or symptoms of disease) are non-covered by Medicare.

Non-invasive vascular studies are reasonable and necessary only if the outcome will potentially impact the clinical course of the patient. Non-invasive vascular studies will be considered not medically reasonable and necessary if the study results will have no impact on the decision for further diagnostic or therapeutic procedures. For example, if it is obvious from the findings of the history and physical examination that the patient is going to proceed to angiography, then non-invasive vascular studies are not necessary.

The following considerations apply to Duplex scans, Doppler Ultrasound with Spectrum Analysis, Ocular Pneumoplethysmography, and Periorbital Doppler (CPT codes 93875, 93880, and 93882):

  • Ocular transient ischemic attacks are defined as visual field deficits and not temporary blurred vision.
  • Although episodic dizziness/vertigo may be a symptom of transient ischemic attack, the medical record should document that more common causes of dizziness/vertigo, (e.g., postural hypotension, arrhythmia, decreased cardiac output) were ruled-out prior to evaluation with duplex ultrasonography.
  • Headaches, other than basilar, hemiplegic and classical with intractable migraine are not indications for extracranial arterial studies.
  • "Drop attacks," or syncope, may be considered reasonable and necessary if there is documented suspicion that the symptoms are associated with vertebrobasilar or bilateral carotid artery disease.
  • Extracranial artery studies performed as part of a cardiovascular preoperative workup in the absence of signs or symptoms of disease are screening services and as such are non-covered by Medicare.
  • Subclavian ultrasound studies routinely performed in conjunction with carotid ultrasounds in the absence of signs or symptoms of disease are screening services and as such are non-covered by Medicare.

The following indications are considered not medically reasonable and necessary for TCD (CPT codes 93886, 93888, 93890, 93892 and 93893):

  • Evaluation of brain tumors
  • Assessment of familial and degenerative diseases of the cerebrum, brainstem, cerebellum, basal ganglia and motor neurons
  • Evaluation of infectious and inflammatory conditions
  • Evaluation of psychiatric disorders
  • Epilepsy

The following indications for TCD (procedure codes 93886, 93888, 93890, 93892 and 93893) are considered investigational and will be denied as not medically reasonable and necessary:

  • Assessing patients with migraine or headache
  • Monitoring during cardiopulmonary bypass and other cerebrovascular and cardiovascular interventions, and other surgical procedures
  • Evaluation of patients with dilated vasculopathies such as fusiform aneurysms
  • Assessing autoregulation, physiologic, and pharmacological responses of cerebral arteries
  • Evaluating children with various vasculopathies such as sickle cell disease, moya moya, and neurofibromatosis

The following methods are not acceptable for reimbursement of CPT codes 93875-93893:

  • Thermography
  • Mechanical oscillometry
  • Inductance plethysmography
  • Capitance plethysmography
  • Photoelectric plethysmography
  • Light reflection rheography
  • Pulse Delay Oculoplethysmography
  • Carotid Phonoangiography and other forms of bruit analysis are included in the reimbursement for the office visit
  • Periorbital Photoplethysmography

Duplex post-interventional follow-up studies are typically limited in scope and unilateral in nature. The "complete" duplex scan codes should seldom be used, while the" unilateral or limited study" codes should be used (except for the patient who had bilateral intervention).

It is usually unnecessary to perform more than one type of physiological study on the same anatomic area. When an uninterpretable study results in performing another type of study, only the successful study should be billed. Code 93875 will rarely be reimbursed.

It would be expected that a service billed with code 93880 would be used as the initial non-invasive diagnostic test. In rare instances where the service billed with code 93880 is not available, the code 93875 service may be performed where it is reasonable and necessary. Otherwise, 93875 should be substituted with 93880, which has a higher accuracy rate.

Physiologic studies and a duplex scan performed on the same day will be considered medically necessary if there is a 50 percent stenosis demonstrated on the duplex scan, or there are significant symptoms present.

The accuracy of noninvasive vascular diagnostic studies depends on the knowledge, skill, and experience of the technologist and physician performing and interpreting the study. Consequently, the physician performing and/or interpreting the study must be capable of demonstrating documented training and experience and maintain any applicable documentation. A vascular diagnostic study may be personally performed by a physician or a technologist.

All non-invasive vascular diagnostic studies performed by a technologist must be performed by, or under the direct supervision of, a technologist who has demonstrated competency by being credentialed in vascular technology, or, such studies must be performed in a facility accredited by the Intersocietal Commission for the Accreditation of Vascular Laboratories (ICAVL) or the Non-Invasive Vascular Ultrasound Accreditation of the American College of Radiology (ACR). Examples of appropriate certification include the Registered Vascular Technologist (RVT) credential and the Registered Cardiovascular Technologist (RCVT) credential in Vascular Technology. Direct supervision requires the credentialed individual's presence in the facility and immediate availability to the technologist performing the study.

Coverage Topic

Diagnostic Tests and X-Rays

Coding Information

Bill Type Codes

Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the policy does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the policy should be assumed to apply equally to all claims.

11x

Hospital-inpatient (including Part A)

12x

Hospital-inpatient or home health visits (Part B only)

13x

Hospital-outpatient (HHA-A also) (under OPPS 13X must be used for ASC claims submitted for OPPS payment -- eff. 7/00)

83x

Special facility or ASC surgery-ambulatory surgical center (Discontinued for Hospitals Subject to Outpatient PPS; hospitals must use 13X for ASC claims submitted for OPPS payment -- eff. 7/00)

85x

Special facility or ASC surgery-rural primary care hospital (eff 10/94)

 

Revenue Codes

Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory; unless specified in the policy services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates that coverage is not influenced by Revenue Code and the policy should be assumed to apply equally to all Revenue Codes.

0921

Other diagnostic services-peripheral vascular lab

 

CPT/HCPCS Codes

Italicized and/or quoted material is excerpted from the American Medical Association, Current Procedural Terminology (CPT) codes.

93875

NONINVASIVE PHYSIOLOGIC STUDIES OF EXTRACRANIAL ARTERIES, COMPLETE BILATERAL STUDY (EG, PERIORBITAL FLOW DIRECTION WITH ARTERIAL COMPRESSION, OCULAR PNEUMOPLETHYSMOGRAPHY, DOPPLER ULTRASOUND SPECTRAL ANALYSIS)

93880

DUPLEX SCAN OF EXTRACRANIAL ARTERIES; COMPLETE BILATERAL STUDY

93882

DUPLEX SCAN OF EXTRACRANIAL ARTERIES; UNILATERAL OR LIMITED STUDY

93886

TRANSCRANIAL DOPPLER STUDY OF THE INTRACRANIAL ARTERIES; COMPLETE STUDY

93888

TRANSCRANIAL DOPPLER STUDY OF THE INTRACRANIAL ARTERIES; LIMITED STUDY

93890

TRANSCRANIAL DOPPLER STUDY OF THE INTRACRANIAL ARTERIES; VASOREACTIVITY STUDY

93892

TRANSCRANIAL DOPPLER STUDY OF THE INTRACRANIAL ARTERIES; EMBOLI DETECTION WITHOUT INTRAVENOUS MICROBUBBLE INJECTION

93893

TRANSCRANIAL DOPPLER STUDY OF THE INTRACRANIAL ARTERIES; EMBOLI DETECTION WITH INTRAVENOUS MICROBUBBLE INJECTION

 

ICD-9 Codes that Support Medical Necessity

It is the provider’s responsibility to select codes carried out to the highest level of specificity and selected from the ICD-9-CM code book appropriate to the year in which the service is rendered for the claim(s) submitted.

For CPT codes 93875, 93880, and 93882:

237.3

 

NEOPLASM OF UNCERTAIN BEHAVIOR OF PARAGANGLIA

342.00 - 342.92

FLACCID HEMIPLEGIA AND HEMIPARESIS AFFECTING UNSPECIFIED SIDE - UNSPECIFIED HEMIPLEGIA AND HEMIPARESIS AFFECTING NONDOMINANT SIDE

344.00 - 344.9

QUADRIPLEGIA UNSPECIFIED - PARALYSIS UNSPECIFIED

346.01

CLASSICAL MIGRAINE WITH INTRACTABLE MIGRAINE SO STATED

346.20 - 346.21

VARIANTS OF MIGRAINE WITHOUT INTRACTABLE MIGRAINE - VARIANTS OF MIGRAINE WITH INTRACTABLE MIGRAINE SO STATED

346.80 - 346.81

OTHER FORMS OF MIGRAINE WITHOUT INTRACTABLE MIGRAINE - OTHER FORMS OF MIGRAINE WITH INTRACTABLE MIGRAINE SO STATED

348.8*

OTHER CONDITIONS OF BRAIN

362.30 - 362.37

RETINAL VASCULAR OCCLUSION UNSPECIFIED - VENOUS ENGORGEMENT OF RETINA

362.84

RETINAL ISCHEMIA

364.42

RUBEOSIS IRIDIS

368.10 - 368.12

SUBJECTIVE VISUAL DISTURBANCE UNSPECIFIED - TRANSIENT VISUAL LOSS

368.2

DIPLOPIA

368.40 - 368.47

VISUAL FIELD DEFECT UNSPECIFIED - HETERONYMOUS BILATERAL FIELD DEFECTS

431

INTRACEREBRAL HEMORRHAGE

433.00 - 433.91

OCCLUSION AND STENOSIS OF BASILAR ARTERY WITHOUT CEREBRAL INFARCTION - OCCLUSION AND STENOSIS OF UNSPECIFIED PRECEREBRAL ARTERY WITH CEREBRAL INFARCTION

434.00 - 434.91

CEREBRAL THROMBOSIS WITHOUT CEREBRAL INFARCTION - CEREBRAL ARTERY OCCLUSION UNSPECIFIED WITH CEREBRAL INFARCTION

435.0 - 435.9

BASILAR ARTERY SYNDROME - UNSPECIFIED TRANSIENT CEREBRAL ISCHEMIA

436

ACUTE BUT ILL-DEFINED CEREBROVASCULAR DISEASE

437.0 - 437.1

CEREBRAL ATHEROSCLEROSIS - OTHER GENERALIZED ISCHEMIC CEREBROVASCULAR DISEASE

437.3 - 437.5

CEREBRAL ANEURYSM NONRUPTURED - MOYAMOYA DISEASE

437.7

TRANSIENT GLOBAL AMNESIA

437.9

UNSPECIFIED CEREBROVASCULAR DISEASE

442.81 - 442.82

ANEURYSM OF ARTERY OF NECK - ANEURYSM OF SUBCLAVIAN ARTERY

443.21

DISSECTION OF CAROTID ARTERY

444.9*

EMBOLISM AND THROMBOSIS OF UNSPECIFIED ARTERY

446.0 - 446.7

POLYARTERITIS NODOSA - TAKAYASU'S DISEASE

447.0 - 447.2

ARTERIOVENOUS FISTULA ACQUIRED - RUPTURE OF ARTERY

447.6

ARTERITIS UNSPECIFIED

447.8 - 447.9

OTHER SPECIFIED DISORDERS OF ARTERIES AND ARTERIOLES - UNSPECIFIED DISORDERS OF ARTERIES AND ARTERIOLES

449

SEPTIC ARTERIAL EMBOLISM

780.2*

SYNCOPE AND COLLAPSE

781.2 - 781.4

ABNORMALITY OF GAIT - TRANSIENT PARALYSIS OF LIMB

781.94

FACIAL WEAKNESS

782.0

DISTURBANCE OF SKIN SENSATION

784.2*

SWELLING MASS OR LUMP IN HEAD AND NECK

784.3

APHASIA

784.5

OTHER SPEECH DISTURBANCE

785.9*

OTHER SYMPTOMS INVOLVING CARDIOVASCULAR SYSTEM

787.20 - 787.29

DYSPHAGIA, UNSPECIFIED - OTHER DYSPHAGIA

900.00 - 900.9

INJURY TO CAROTID ARTERY UNSPECIFIED - INJURY TO UNSPECIFIED BLOOD VESSEL OF HEAD AND NECK

901.1

INJURY TO INNOMINATE AND SUBCLAVIAN ARTERIES

958.4

TRAUMATIC SHOCK

996.1

MECHANICAL COMPLICATION OF OTHER VASCULAR DEVICE IMPLANT AND GRAFT

996.70 - 996.79

OTHER COMPLICATIONS DUE TO UNSPECIFIED DEVICE IMPLANT AND GRAFT - OTHER COMPLICATIONS DUE TO OTHER INTERNAL PROSTHETIC DEVICE IMPLANT AND GRAFT

998.0 - 998.9

POSTOPERATIVE SHOCK NOT ELSEWHERE CLASSIFIED - UNSPECIFIED COMPLICATION OF PROCEDURE NOT ELSEWHERE CLASSIFIED

V43.4

BLOOD VESSEL REPLACED BY OTHER MEANS

V45.89

OTHER POSTSURGICAL STATUS

V58.49

OTHER SPECIFIED AFTERCARE FOLLOWING SURGERY

V67.00

FOLLOW-UP EXAMINATION FOLLOWING UNSPECIFIED SURGERY

V67.09

FOLLOW-UP EXAMINATION FOLLOWING OTHER SURGERY

*Note: Use code 348.8 to identify assessment of Suspected Brain Death; use code 444.9 to report Paradoxical Cerebral Embolism; use code 780.2 when symptomatology indicates a strong clinical suspicion of vertebrobasilar insufficiency; use code 784.2 to report Pulsatile Neck Mass; use code 785.9 to report Carotid Bruit.


For CPT codes 93886, 93888, 93890, 93892, and 93893:

282.60 - 282.69

SICKLE-CELL DISEASE UNSPECIFIED - OTHER SICKLE-CELL DISEASE WITH CRISIS

348.8*

OTHER CONDITIONS OF BRAIN

362.30 - 362.37

RETINAL VASCULAR OCCLUSION UNSPECIFIED - VENOUS ENGORGEMENT OF RETINA

362.84

RETINAL ISCHEMIA

364.42

RUBEOSIS IRIDIS

368.10 - 368.12

SUBJECTIVE VISUAL DISTURBANCE UNSPECIFIED - TRANSIENT VISUAL LOSS

368.2

DIPLOPIA

368.40 - 368.47

VISUAL FIELD DEFECT UNSPECIFIED - HETERONYMOUS BILATERAL FIELD DEFECTS

430

SUBARACHNOID HEMORRHAGE

431

INTRACEREBRAL HEMORRHAGE

433.00 - 433.21

OCCLUSION AND STENOSIS OF BASILAR ARTERY WITHOUT CEREBRAL INFARCTION - OCCLUSION AND STENOSIS OF VERTEBRAL ARTERY WITH CEREBRAL INFARCTION

433.80 - 433.91

OCCLUSION AND STENOSIS OF OTHER SPECIFIED PRECEREBRAL ARTERY WITHOUT CEREBRAL INFARCTION - OCCLUSION AND STENOSIS OF UNSPECIFIED PRECEREBRAL ARTERY WITH CEREBRAL INFARCTION

434.00 - 434.91

CEREBRAL THROMBOSIS WITHOUT CEREBRAL INFARCTION - CEREBRAL ARTERY OCCLUSION UNSPECIFIED WITH CEREBRAL INFARCTION

435.0 - 435.9

BASILAR ARTERY SYNDROME - UNSPECIFIED TRANSIENT CEREBRAL ISCHEMIA

436

ACUTE BUT ILL-DEFINED CEREBROVASCULAR DISEASE

437.0 - 437.1

CEREBRAL ATHEROSCLEROSIS - OTHER GENERALIZED ISCHEMIC CEREBROVASCULAR DISEASE

437.3 - 437.5

CEREBRAL ANEURYSM NONRUPTURED - MOYAMOYA DISEASE

437.7

TRANSIENT GLOBAL AMNESIA

437.9

UNSPECIFIED CEREBROVASCULAR DISEASE

442.81 - 442.82

ANEURYSM OF ARTERY OF NECK - ANEURYSM OF SUBCLAVIAN ARTERY

444.9*

EMBOLISM AND THROMBOSIS OF UNSPECIFIED ARTERY

446.0 - 446.29

POLYARTERITIS NODOSA - OTHER SPECIFIED HYPERSENSITIVITY ANGIITIS

447.0 - 447.2

ARTERIOVENOUS FISTULA ACQUIRED - RUPTURE OF ARTERY

447.6

ARTERITIS UNSPECIFIED

447.8 - 447.9

OTHER SPECIFIED DISORDERS OF ARTERIES AND ARTERIOLES - UNSPECIFIED DISORDERS OF ARTERIES AND ARTERIOLES

449

SEPTIC ARTERIAL EMBOLISM

747.81

CONGENITAL ANOMALIES OF CEREBROVASCULAR SYSTEM

780.2*

SYNCOPE AND COLLAPSE

781.2 - 781.5

ABNORMALITY OF GAIT - CLUBBING OF FINGERS

781.94

FACIAL WEAKNESS

782.0

DISTURBANCE OF SKIN SENSATION

784.3

APHASIA

784.5

OTHER SPEECH DISTURBANCE

785.9*

OTHER SYMPTOMS INVOLVING CARDIOVASCULAR SYSTEM

787.20 - 787.29

DYSPHAGIA, UNSPECIFIED - OTHER DYSPHAGIA

900.00 - 900.9

INJURY TO CAROTID ARTERY UNSPECIFIED - INJURY TO UNSPECIFIED BLOOD VESSEL OF HEAD AND NECK

901.1

INJURY TO INNOMINATE AND SUBCLAVIAN ARTERIES

958.4

TRAUMATIC SHOCK

996.1

MECHANICAL COMPLICATION OF OTHER VASCULAR DEVICE IMPLANT AND GRAFT

996.74

OTHER COMPLICATIONS DUE TO OTHER VASCULAR DEVICE IMPLANT AND GRAFT

998.11 - 998.4

HEMORRHAGE COMPLICATING A PROCEDURE - FOREIGN BODY ACCIDENTALLY LEFT DURING A PROCEDURE NOT ELSEWHERE CLASSIFIED

998.6 - 998.7

PERSISTENT POSTOPERATIVE FISTULA NOT ELSEWHERE CLASSIFIED - ACUTE REACTION TO FOREIGN SUBSTANCE ACCIDENTALLY LEFT DURING A PROCEDURE NOT ELSEWHERE CLASSIFIED

V43.4

BLOOD VESSEL REPLACED BY OTHER MEANS

V67.00

FOLLOW-UP EXAMINATION FOLLOWING UNSPECIFIED SURGERY

V67.09

FOLLOW-UP EXAMINATION FOLLOWING OTHER SURGERY

*Note: Use code 348.8 to identify assessment of Suspected Brain Death; use code 444.9 to report Paradoxical Cerebral Embolism; use code 780.2 when symptomatology indicates a strong clinical suspicion of vertebrobasilar insufficiency; use code 785.9 to report Carotid Bruit.

 

Diagnoses that Support Medical Necessity

N/A

ICD-9 Codes that DO NOT Support Medical Necessity

All those not listed under the “ICD-9 Codes that Support Medical Necessity” section of this policy.

ICD-9 Codes that DO NOT Support Medical Necessity Asterisk Explanation

 

Diagnoses that DO NOT Support Medical Necessity

Conditions that are not listed in the "ICD-9-CM Codes that Support Medical Necessity" section of this policy.

General Information

Documentation Requirements

  1. All documentation must be maintained in the patient’s medical record and available to the contractor upon request.

  2. Every page of the record must be legible and include appropriate patient identification information (e.g., complete name, dates of service(s)). The record must include the physician or non-physician practitioner responsible for and providing the care of the patient.

  3. The submitted medical record should support the use of the selected ICD-9-CM code(s). The submitted CPT/HCPCS code should describe the service performed.

  4. The patient's medical record must contain a current, pertinent history and physical examination, and progress notes describing and supporting the indications for the services.

  5. The medical record must contain any pertinent prior diagnostic testing and completed report(s).

  6. Documentation must support the medical necessity of subclavian ultrasound performed in conjunction with a carotid ultrasound study. The medical record must include documentation of signs and/or symptoms of disease to support the medical necessity of the subclavian scan.

Utilization Guidelines

In accordance with CMS Ruling 95-1 (V), utilization of these services should be consistent with locally acceptable standards of practice.

For follow up of patients with known carotid disease who are receiving medical therapy:

  • Stenosis of 20 percent to 50 percent (diameter reduction) - annual study.
  • Stenosis of 50 percent to 99 percent (diameter reduction) - every six months.
  • Medicare expects that few patients with high-grade carotid stenosis (79-99 percent) will be followed medically with repeated diagnostic testing. Because surgery is usually indicated for stenosis of 80 percent to 99 percent, the medical record of patients followed medically with high-grade stenosis must unequivocally indicate medical necessity for repeated diagnostic testing.

Medicare would not expect, after carotid endarterectomy, that repeat examinations occur more frequently than at six weeks, six months, 12 months, initially and yearly, thereafter. Postoperatively, follow-up studies should be unilateral, unless signs and symptoms or known contralateral stenosis provide indications for a bilateral procedure.

Sources of Information and Basis for Decision

Other Contractor’s Policies

Highmark Medicare Services Contractor Medical Directors

Advisory Committee Meeting Notes

This policy does not reflect the sole opinion of the contractor or Contractor Medical Directors. Although the final decision rests with the contractor, this policy was developed in cooperation with advisory groups, which includes representatives from the appropriate specialty (ies).

CAC/IAC Distribution:  04/01/2008

Start Date of Comment Period

04/01/2008

End Date of Comment Period:

05/15/2008

Start Date of Notice Period

05/23/2008

Revision History

Revision History Number

L27504

Revision History Explanation

DatePolicy #Description

08/01/2008

L27504

LCD effective 08/01/2008 for DC Part A, Maryland Part A, and Pennsylvania Part A. LCD is now effective for DC Part A and DCMA Part B; Maryland Part A and Maryland Part B; Pennsylvania Part A; and Delaware Part B.

05/23/2008

L27504

Original LCD posted for notice. LCD to become effective 07/11/2008 for Maryland Part B, DCMA Part B and Delaware Part B.

04/01/2008

Draft J12-D29

Original LCD posted for comment.

Last Reviewed On

07/31/2008

Related Documents

This LCD has no Related Documents.

LCD Attachments

There are no attachments for this LCD.

© 2005-2008. All rights are reserved.